CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Cash flows provided by (used in) operating activities
Net earnings	$ 156.7	$ 183.1
(Loss) earnings from discontinued operations, net of tax	(1.5)	11.0
Net earnings from continuing operations	158.2	172.1
Adjustments to reconcile net income to net cash provided by operating activities of continuing operations:
Depreciation	52.1	46.5
Amortization	13.4	13.5
Share-based compensation	10.0	9.8
Deferred income taxes	5.4	18.8
Pension and postretirement benefit (income) expense	(2.3)	0.7
Contributions to pension and postretirement plans	(11.6)	(10.6)
Non-cash loss on disposal of assets	0.9	1.9
Unrealized (gain) loss on foreign currency forward contracts	(5.8)	7.9
Changes in operating assets and liabilities:
Trade accounts receivable	(38.0)	(50.1)
Other receivables	4.3	(5.6)
Inventories	(11.8)	(48.7)
Other assets	(5.0)	1.1
Accounts payable	13.3	22.4
Accrued expenses	(19.0)	(1.6)
Income taxes payable	(2.5)	4.2
Other liabilities	(1.6)	(10.6)
Net cash provided by operating activities of continuing operations	160.0	171.7
Net cash (used in) provided by operating activities of discontinued operations	(3.2)	0.3
Net cash provided by operating activities	156.8	172.0
Cash flows used in investing activities:
Additions to plants, equipment and facilities	(96.9)	(170.3)
Other investing activities, net	0.0	(0.1)
Net cash used in investing activities	(96.9)	(170.4)
Cash flows provided by (used in) financing activities:
Proceeds from long-term debt	0.5	1.3
Payments on long-term debt	(0.9)	(0.4)
Proceeds from (Repayments of) Short-term Debt	0.0	2.9
Dividends, Cash	(26.8)	(17.9)
Proceeds from the exercise of stock options	9.9	14.3
Excess tax benefits from share-based payment arrangements	3.8	6.7
Net cash (used in) provided by financing activities	(13.5)	6.9
Effect of currency rate changes on cash and cash equivalents	(9.4)	(7.7)
Increase in cash and cash equivalents	37.0	0.8
Cash and cash equivalents, beginning of period	133.9	151.8
Cash and cash equivalents, end of period	$ 170.9	$ 152.6